Search Results - "Finberg, J"

Refine Results
  1. 1

    Neuroprotective effect of weak static magnetic fields in primary neuronal cultures by Ben Yakir-Blumkin, M, Loboda, Y, Schächter, L, Finberg, J.P.M

    Published in Neuroscience (10-10-2014)
    “…Highlights • We examined the pro-survival effect exerted by weak SMFs in primary neuronal cultures. • SMF-exposure reduces induced apoptosis in primary…”
    Get full text
    Journal Article
  2. 2

    Increased L‐DOPA‐derived dopamine following selective MAO‐A or ‐B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation by Sader‐Mazbar, O, Loboda, Y, Rabey, M J, Finberg, J P M

    Published in British journal of pharmacology (01-11-2013)
    “…Background and Purpose Selective MAO type B (MAO‐B) inhibitors are effective in potentiation of the clinical effect of L‐DOPA in Parkinson's disease, but…”
    Get full text
    Journal Article
  3. 3

    Analysis of volatile organic compounds in rats with dopaminergic lesion: Possible application for early detection of Parkinson’s disease by Khatib, S., Finberg, J.P.M., Artoul, F., Lavner, Y., Mahmood, S., Tisch, U., Haick, H., Aluf, Y., Vaya, J.

    Published in Neurochemistry international (01-10-2014)
    “…•Dopaminergic neurons depleted rats were used as model for pre-Parkinsonian animal.•Volatile organic compounds (VOCs) as biomarkers were found in their blood…”
    Get full text
    Journal Article
  4. 4

    Distinguishing idiopathic Parkinson's disease from other parkinsonian syndromes by breath test by Nakhleh, M.K, Badarny, S, Winer, R, Jeries, R, Finberg, J, Haick, H

    Published in Parkinsonism & related disorders (01-02-2015)
    “…Abstract Introduction Diagnosis of different parkinsonian syndromes is linked with high misdiagnosis rates and various confounding factors. This is…”
    Get full text
    Journal Article
  5. 5

    Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule by Aluf, Y., Vaya, J., Khatib, S., Finberg, J.P.M.

    Published in Neuropharmacology (01-07-2011)
    “…Oxidative stress (OS) is thought to participate in neurodegenerative diseases such as Parkinson’s disease, but the contribution of dopamine metabolism and…”
    Get full text
    Journal Article
  6. 6

    A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice by Finberg, M. J., Muntingh, G. L., van Rensburg, C. E. J.

    Published in Inflammopharmacology (01-12-2015)
    “…Aloe vera gel is widely used in the treatment of an array of disturbances, especially skin disorders. The wound-healing effects have been attributed to its…”
    Get full text
    Journal Article
  7. 7

    Cardiovascular responses to combined treatment with selective monoamine oxidase type B inhibitors and L‐DOPA in the rat by Finberg, J P M, Gross, A, Bar‐Am, O, Friedman, R, Loboda, Y, Youdim, M B H

    Published in British journal of pharmacology (01-11-2006)
    “…Background and purpose: Postural hypotension is a common side‐effect of L‐DOPA treatment of Parkinson's disease, and may be potentiated when L‐DOPA is combined…”
    Get full text
    Journal Article
  8. 8

    Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule by Aluf, Y, Vaya, J, Khatib, S, Loboda, Y, Kizhner, S, Finberg, John P M

    Published in Free radical research (2010)
    “…Real time oxidative stress in the extracellular compartment of rat striatum was characterized by microdialysis with synthetic non-dialyzable marker molecules…”
    Get more information
    Journal Article
  9. 9
  10. 10

    The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons by Ben-Shachar, D, Eshel, G, Finberg, J P, Youdim, M B

    Published in Journal of neurochemistry (01-04-1991)
    “…A selective increase in content of iron in the pars compacta of the substantia nigra has been implicated in the biochemical pathology of Parkinson's disease…”
    Get more information
    Journal Article
  11. 11

    Modification of L-DOPA pharmacological activity by MAO inhibitors by Finberg, J P M, Sader-Mazbar, O

    Published in Journal of Neural Transmission (01-06-2007)
    “…Dopamine behaves mainly as a MAO-A substrate in rodent brain, but selective inhibition of MAO-B results in an increased turning activity following L-DOPA…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section by Finberg, H J, Williams, J W

    Published in Journal of ultrasound in medicine (01-07-1992)
    “…A prospective evaluation for possible placenta accreta was performed in 34 patients with placenta previa and a history of one or more cesarean sections…”
    Get more information
    Journal Article
  15. 15

    Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo by Lamensdorf, I, Youdim, M B, Finberg, J P

    Published in Journal of neurochemistry (01-10-1996)
    “…Acute inhibition of monoamine oxidase B (MAO-B) in the rat does not affect striatal dopamine (DA) metabolism, but chronic MAO-B inhibition with deprenyl has…”
    Get more information
    Journal Article
  16. 16

    Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea‐pig by Ilani, T, Lamensdorf, I, Finberg, J P M

    Published in British journal of pharmacology (01-08-2000)
    “…Striatal microdialysate levels of dopamine (DA) in conscious guinea‐pigs were measured following acute (1 day) and chronic (21 days) treatment with deprenyl (2…”
    Get full text
    Journal Article
  17. 17

    Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation by GASSEN, M, LAMENSDORF, I, ARMONY, T, FINBERG, J. P. M, YOUDIM, M. B. H

    Published in Journal of Neural Transmission (01-02-2003)
    “…Flupirtine is a triaminopyridine derived centrally acting analgetic, which has been found to display neuroprotective effects in models of excitotoxic cell…”
    Get full text
    Journal Article
  18. 18

    Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor by M. Finberg, John P, Takeshima, Takao, Johnston, Jane M, Commissiong, John W

    Published in Neuroreport (09-03-1998)
    “…BOTH deprenyl and rasagiline (R(+)-N-propargyl-1–aminoindane mesylate), at a concentration of 1–1 μM, increased survival in vitro of rat E14 mesencephalic…”
    Get full text
    Journal Article
  19. 19

    Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats by Finberg, J P, Wang, J, Goldstein, D S, Kopin, I J, Bankiewicz, K S

    Published in Journal of neurochemistry (01-09-1995)
    “…The effect of selective inhibition of monoamine oxidase (MAO) subtypes A and B on striatal metabolism of DOPA to dopamine (DA), 3,4-dihydroxyphenylacetic acid…”
    Get more information
    Journal Article
  20. 20

    The "twin peak" sign: reliable evidence of dichorionic twinning by Finberg, H J

    Published in Journal of ultrasound in medicine (01-11-1992)
    “…In twin pregnancies with a single placental zone, the presence of a triangular projection of placental tissue beyond the chorionic surface, extending between…”
    Get more information
    Journal Article